Cardiff Oncology, Inc. (CRDF)
1.58
-0.02
(-1.25%)
USD |
NASDAQ |
Feb 12, 16:00
1.61
+0.03
(+1.90%)
Pre-Market: 09:26
Cardiff Oncology Free Cash Flow : -42.27M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Agenus, Inc. | -89.31M |
| Curis, Inc. | -30.09M |
| LadRx Corp. | -- |
| Windtree Therapeutics, Inc. | -15.12M |
| Enzon Pharmaceuticals, Inc. | -2.102M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.83M |
| Cash from Investing (Quarterly) | 10.16M |
| Cash from Financing (Quarterly) | 0.025M |
| Free Cash Flow Per Share (Quarterly) | -0.1623 |
| Free Cash Flow to Equity (Quarterly) | -10.68M |
| Free Cash Flow to Firm (Quarterly) | -10.85M |
| Free Cash Flow Yield | -41.93% |